Parallel Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
|
|||||
|
2025
Q1 | $2.22M | Sell |
|
|||||
|
2024
Q4 | $3.83M | Buy |
|
|||||
|
2024
Q3 | $4.05M | Sell |
|
|||||
|
2024
Q2 | $3.8M | Sell |
|
|||||
|
2024
Q1 | $3.91M | Sell |
|
|||||
|
2023
Q4 | $3.75M | Buy |
|
|||||
|
2023
Q3 | $3M | Buy |
|
|||||
|
2023
Q2 | $3.4M | Buy |
|
|||||
|
2023
Q1 | $3.09M | Buy |
|
|||||
|
2022
Q4 | $757K | Sell |
|
|||||
|
2022
Q3 | $759K | Sell |
|
|||||
|
2022
Q2 | $738K | Buy |
|
|||||
|
2022
Q1 | $835K | Sell |
|
|||||
|
2021
Q4 | $1.03M | Buy |
|
|||||
|
2021
Q3 | $1.11M | Sell |
|
|||||
|
2021
Q2 | $1.22M | Sell |
|
|||||
|
2021
Q1 | $1.22M | Sell |
|
|||||
|
2020
Q4 | $1.27M | Buy |
|
|||||
|
2020
Q3 | $997K | Sell |
|
|||||
|
2020
Q2 | $1.06M | Sell |
|
|||||
|
2020
Q1 | $761K | Sell |
|
|||||
|
2019
Q4 | $987K | Buy |
|
|||||
|
2019
Q3 | $776K | Buy |
|
|||||
|
2019
Q2 | $883K | Buy |
|
|||||
|
2019
Q1 | $880K | Sell |
|
|||||
|
2018
Q4 | $708K | Buy |
|
|||||
|
2018
Q3 | $944K | Buy |
|
|||||
|
2018
Q2 | $899K | Sell |
|
|||||
|
2018
Q1 | $835K | Buy |
|
|||||
|
2017
Q4 | $788K | Buy |
|
|||||
|
2017
Q3 | $714K | Buy |
|
|||||
|
2017
Q2 | $668K | Sell |
|
|||||
|
2017
Q1 | $604K | Buy |
|
|||||
|
2016
Q4 | $432K | Buy |
|